Rexulti (brexpiprazole)

pCPA File Number: 21025
Negotiation Status:
Concluded with an LOI
Indication(s):
Schizophrenia
Sponsor/Manufacturer:
Otsuka Canada Pharmaceutical Inc.
CDA-AMC Project Number:
SR0514-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: